Is onychomycosis a risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onychomycosis Is a Significant Health Risk Beyond Cosmetic Concerns

Yes, onychomycosis poses significant health risks beyond cosmetic concerns, including potential complications such as bacterial infections, foot ulcers, and systemic health issues, particularly in vulnerable populations. 1

Clinical Risks of Untreated Onychomycosis

  • Onychomycosis can disrupt skin integrity, providing an entry point for bacteria that may lead to foot ulcers, osteomyelitis, cellulitis, and gangrene, especially in diabetic patients 1
  • Infected nails serve as a fungal reservoir with potential for spread to other body areas including feet, hands, and groin 1
  • The infection is contagious and may spread to other family members if left untreated 1
  • Fungal antigens in the nail plate may predispose individuals to other clinical conditions including asthma/respiratory tract sensitization, atopic dermatitis, urticaria, and erythema nodosum 1

Impact on Quality of Life

  • Approximately 50% of patients with onychomycosis experience pain or discomfort 1
  • About 30% of patients have difficulty wearing footwear 1
  • Patients commonly report difficulty walking, emotional embarrassment, and work-related difficulties 1
  • Severe cases may negatively impact patients' sex lives 1
  • Damaged socks and stockings from friction with sharp, dystrophic nails create additional burdens 1

High-Risk Populations

  • Immunocompromised patients face more serious health problems from onychomycosis 2
  • Patients with diabetes or peripheral vascular disease are at increased risk for complications such as cellulitis 1
  • Elderly individuals have higher prevalence rates (20% in those over 60 years, up to 50% in those over 70) 2
  • Transplant recipients and individuals on immunosuppressive treatments are particularly vulnerable 1, 2

Public Health Considerations

  • Onychomycosis is highly contagious, with fungal elements protected in small pieces of keratin that can contaminate communal bathing places 1
  • Treatment reduces disease prevalence by decreasing the number of infected individuals who can spread the infection 1
  • The infection is a significant cause of medical consultation and work absence 1

Common Misconceptions and Pitfalls

  • It is a common misconception that onychomycosis is merely a cosmetic problem that doesn't require treatment 1
  • The most common cause of treatment failure in the UK is incorrect diagnosis made on clinical grounds alone without laboratory confirmation 1
  • High reinfection and recurrence rates make proper diagnosis and complete treatment essential 3
  • Onychomycosis should be differentiated from other nail disorders like onychotillomania that require completely different treatments 4

Treatment Considerations

  • Oral antifungals (terbinafine, itraconazole) generally have higher cure rates but carry risks of side effects 5, 6
  • Topical treatments have more favorable safety profiles but lower efficacy and longer treatment periods 6
  • Treatment selection should consider disease severity, infecting pathogen, medication safety, efficacy, cost, and patient factors 6
  • Mycological cure rates are typically about 30% better than clinical cure rates in most studies 1

Onychomycosis should be considered a legitimate medical concern requiring proper diagnosis and treatment, not just for cosmetic improvement but to prevent potentially serious complications and improve quality of life 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Onychomycosis Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trastornos de Comportamiento Repetitivo Centrado en el Cuerpo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Updated Perspectives on the Diagnosis and Management of Onychomycosis.

Clinical, cosmetic and investigational dermatology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.